Drug intelligence / Profile preview

Losartan + atorvastatin

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Losartan + atorvastatin is a fixed-dose combination of two small molecule drugs used to treat patients with both hypertension and hypercholesterolemia. Losartan is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the binding of angiotensin II to the type 1 angiotensin II receptor, resulting in vasodilation. Atorvastatin is a statin that inhibits HMG-CoA reductase, reducing cholesterol synthesis in the liver and lowering blood lipid levels. The combination provides additive or synergistic cardiovascular protection, improving endothelial function and reducing risk factors for heart attack and stroke. Mechanistically, their combined effect may be mediated through increased nitric oxide bioavailability in vascular endothelium, leading to improved vasorelaxation and cardioprotection[1][2][3][5].

02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)AGTR1 (Angiotensin II Type-1 receptor)

Beyond the preview

Go deeper on Losartan + atorvastatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Losartan + atorvastatin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call